Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight off competition from rivals in a highly competitive market. The company announced the completion of two trials of its GLP-1 class drug…
CRO IQVIA Faulted by FDA for Data Inaccuracy, Quality Issues in Opioid Sales Database
The FDA took vendor IQVIA to task for a discrepancy in data regarding sales of opioid drug products that the agency said could undermine forecasts used in the fight against addiction. IQVIA collects data to measure the volume of drugs…
Clinical Trial Agreements: Do You Understand All the Important Terms in the Contract?
Do you understand everything you need to about the clinical trial agreement contracts you sign? Likely not, as most contain hidden landmines and not everything in them is as simple as you might think, according to Eric Babineaux, legal counsel…
Novartis paid $1.2 million to Donald Trump’s personal lawyer
Novartis’ general counsel Felix Ehrat is to step down following revelations that the company paid $1.2 million to Donald Trump’s personal lawyer in return for insights into the president’s health policy ideas. Ehrat said that he is stepping down to…
Novartis completes $8.7bn acquisition of AveXis
Novartis has completed its $8.7bn acquisition of US-based clinical stage gene therapy company AveXis via the consummation of a merger of its indirect wholly-owned subsidiary, Novartis AM Merger with and into AveXis. In the merger, each share of AveXis common…
China removes import duties on 28 medicines; India to get boost
China on Thursday said it has removed import duties on as many as 28 medicines, including all cancer drugs, from May 1, a move which would help India to export these pharmaceuticals to the neighbouring country. “China has exempted import…
Wearable Medical Devices Global Market to Reach $19.5B by 2021
The global market for wearable medical devices is expected to nearly $19.5 billion in 2021 at a compound annual growth rate (CAGR) of 28.8% for 2016-2021, according to a new report from Report Linker. The report reveals that the U.S. market for wearable medical…
Novartis app could revolutionise ophthalmic clinical trials
Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis. The FocalView app, which will enable patients with mobility issues to take part in clinical trials, means researchers can…
Shire considers Takeda’s revised £46bn takeover offer
Shire’s board said that it is willing to recommend Takeda Pharmaceutical’s revised acquisition offer of £46bn to its shareholders. As per the revised proposal, Takeda offers to pay nearly £49 per each share of Shire in the form of £21.75…
Glenmark closes Indian trial site over fraud
As regulatory authorities in India move to tighten up oversight of the country’s fast-growing clinical research sector, local company Glenmark Pharmaceuticals has announced the closure of a clinical trial site in Jamnagar, Gujarat state, citing fraudulent activities. Glenmark started using…
